Skip to main content
Logo
European Innovation Council
  • private sector

Resistell

Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics

Resistell AG logo

Overview

Description

Resistell is a Swiss company, founded in 2018 that proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Resistell'  offering is a diagnostic device. The rapid AST method is based on the detection of vibration caused by living bacterial cells. Because the test is growth independent rapid AST,  Resistell can reduce the time taken to get a result from days to hours. Additionally, Resistell provides information on which antibiotic should be used to treat the patient.

Website
Founded

2018

Project
Country
  • Switzerland
Theme
  • Healthcare